December 2020 Performance Highlights
Consolidated gross sales for the month of December 2020 totaled $3.5 million, representing 9% year-over-year growth (compared to December 2019), and 3% sequential monthly growth (compared to November 2020).
Total prescriptions for the month of December 2020 totaled 46,200, representing 3% year-over-year growth (compared to December 2019), and 8.5% sequential monthly growth (compared to November 2020).
340B revenue was approximately $230,000 for the month of December 2020, representing 109% year-over-year growth (compared to December 2019).
Revenues from COVID-19 Rapid Testing totaled a record $345,000 for the month of December 2020, representing 115% sequential monthly growth (compared to November 2020).
In response to a challenging 2020 context, the Company was able to respond with flexibility and strong execution, capitalizing on Progressive Care’s built-in competitive advantages, including its established delivery infrastructure, to drive a seamless transition into a pandemic-ready operational vision. The Company’s strong results owe in part to its ability to shift in stride to a model centered on contactless prescription delivery, a range of digital solutions, and an overall experience for providers and customers that met the needs of its surrounding communities during an uncertain and unpredictable period.
The Company sees its December performance as particularly important given that it closed the year with one of its strongest months, suggesting both momentum and growing resilience.
Progressive Care ( RXMD
Loading...
Loading...
) stands ready to deliver the same strong service to its clients, patients, and providers in 2021 as the pandemic recedes and a more normalized operating environment reasserts itself, providing a further opportunity for the Company to serve its community as a continued strong force on the virus testing front as well as a key player in the effort to efficiently distribute critical vaccine resources.
Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
), commented, “At some point, you’re going to face a test, and 2020 was a litmus test for many companies. We identified it as such at Progressive Care ( RXMD
Loading...
Loading...
) and worked proactively to innovate, and we emerged stronger than ever. It’s hard to find words to express how proud I am of our team, and we all look forward to a gradually normalizing operational environment in 2021.”
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website. Connect and stay in touch with us on social media:
